Biogen (BIIB) Granted EU Approval of SKYCLARYS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Biogen (BIIB) falls as earnings, revenue misses consensus
February 13, 2024 7:24 AM ESTBiogen (NASDAQ: BIIB) shares are down more than 5% premarket Tuesday after the company reported earnings for its latest quarter, missing the consensus profit and revenue estimate.
The biotechnology firm reported fourth-quarter earnings of $2.95 per share, $0.23 worse than the analyst estimate of $3.18.... More

